Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-11-27 2019-11-27
Drug Identification Number 02452081 02452081
Brand name RAN-TADALAFIL RAN-TADALAFIL
Common or Proper name RAN-TADALAFIL RAN-TADALAFIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients TADALAFIL TADALAFIL
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28 28
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-11-15 2019-11-15
Remaining supply date 2019-11-15 2019-11-15
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments